Editorial: Effects of pharmacologic therapy for diabetes mellitus on the endocrine system

V A Giagulli; G Reimondo; P Moghetti

doi:10.3389/fendo.2022.960930

Editorial: Effects of pharmacologic therapy for diabetes mellitus on the endocrine system

Front Endocrinol (Lausanne). 2022 Jul 14:13:960930. doi: 10.3389/fendo.2022.960930. eCollection 2022.

Authors

V A Giagulli^{1

2}, G Reimondo³, P Moghetti⁴

Affiliations

¹ Interdisciplinary Department of Medicine-Section of Internal Medicine, Geriatrics, Endocrinology and Rare Diseases, University of Bari "Aldo Moro", School of Medicine, Bari, Italy.
² Santa Maria Hospital, Gruppo Villa Maria (GVM) Care & Research, Bari, Italy.
³ Internal Medicine, Department of Clinical and Biological Sciences, San Luigi Gonzaga Hospital, University of Turin, Turin, Italy.
⁴ Endocrinology, Diabetes and Metabolism, Department of Medicine, University and Hospital Trust of Verona, Verona, Italy.

No abstract available

Keywords: aldosterone; diabetes mellitus; glucagon-like peptide-1 receptor agonists; growth hormone; parathyroid hormone; sodium-glucose cotransporter-2 inhibitors; testosterone; thyroid hormones.

Publication types

Editorial

MeSH terms

Diabetes Mellitus* / drug therapy
Endocrine System
Glucagon-Like Peptide-1 Receptor
Sodium-Glucose Transporter 2 Inhibitors* / therapeutic use

Substances

Glucagon-Like Peptide-1 Receptor
Sodium-Glucose Transporter 2 Inhibitors